Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism

  • Bonet, Núria
  • Pesqué, David
  • Giménez Arnau, Anna Maria
  • Laayouni, Hafid, 1968-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease., This work has been partially funded by: • PID2021-125106OB-C31 (JIA), PID2020-116709RB-I00 (PP), CNS2022-135101 (PP), PID2023-147531OB-I00 (PP), PID2021-125106OB-C32 (FC), RED2022-134511-T (PP, JIA) and PID2021-125106OB-C33 (OF) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | https://doi.org/10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE | European Union «Next Generation EU/PRTR». • AC21_2/00042 (JIA) and IFI22/00031 (JG-V) grants from the Instituto de Salud Carlos III co-funded by Unión Europea Next Generation EU | Mecanismo para la Recuperación y la Resiliencia (MRR) | Plan de Recuperación, Transformación y Resiliencia (PRTR). • 2021SGR01093 | Agència de Gestió d’Ajuts Universitaris i de Recerca | Generalitat de Catalunya (FC). • 21897/PI/22 (PP) and 21214/FPI/19 (LH-N) | Fundación Séneca, Región de Murcia, Spain.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaró, Jose Manuel
  • Tejedor Vaquero, Sonia, 1988-
  • Magri, Giuliana, 1978-
  • Bonet, Núria
  • Solís Moruno, Manuel, 1993-
  • Cerutti, Andrea, 1965-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
Background: The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. Objectives: To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Methods: Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Results: Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Conclusion: Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms., This work has been partially funded by RTI2018-096824-B-C21 (JIA) and RTI2018-096824-B-C22 (FC) grant from the Spanish Ministry of Science, Innovation and Universities co-funded by Agencia Estatal de Investigación/European Regional Development Fund una manera de hacer Europa. PID2021-125106OB-C31 (JIA) and PID2021-125106OB-C32 (FC) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | 10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE.PI19/01567 grant from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (AM-V).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís Moruno, Manuel, 1993-
  • Batlle Masó, Laura, 1993-
  • Bonet, Núria
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Genomics England Research Consortium
  • Lao Grueso, Oscar, 1976-
  • Aróstegui Gorospe, Juan Ignacio
  • Laayouni, Hafid, 1968-
  • Casals López, Ferran
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Lao, Oscar
  • Arostegui, Juan Ignacio
  • Laayouni, Hafid
  • Casals, Ferran
  • Genomics England Research Consortium
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís-Moruno, Manuel
  • Batlle-Masó, Laura
  • Bonet, Núria
  • Arostegui, Juan Ignacio
  • Casals, Ferran
© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/., Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

  • Molina-López, Cristina
  • Hurtado-Navarro, Laura
  • García Izquierdo, Carlos
  • Angosto-Bazarra, Diego
  • Vallejo, Fernando
  • Tapia-Abellán, Ana
  • Marques-Soares, Joana R.
  • Vargas, Carmen
  • Bujan-Rivas, Segundo
  • Tomás Barberán, Francisco
  • Arostegui, Juan Ignacio
  • Pelegrin, Pablo
Cryopyrin-associated periodic syndrome (CAPS) is an autoinflammatory condition resulting from monoallelic NLRP3 variants that facilitate IL-1β production. Although these are gain-of-function variants characterized by hypersensitivity to cell priming, patients with CAPS and animal models of the disease may present inflammatory flares without identifiable external triggers. Here we find that CAPS-associated NLRP3 variants are forming constitutively active inflammasome, which induce increased basal cleavage of gasdermin D, IL-18 release and pyroptosis, with a concurrent basal pro-inflammatory gene expression signature, including the induction of nuclear receptors 4 A. The constitutively active NLRP3-inflammasome of CAPS is responsive to the selective NLRP3 inhibitor MCC950 and its activation is regulated by deubiquitination. Despite their preactivated state, the CAPS inflammasomes are responsive to activation of the NF-κB pathway. NLRP3-inflammasomes with CAPS-associated variants affect the immunometabolism of the myeloid compartment, leading to disruptions in lipids and amino acid pathways and impaired glycolysis, limiting IL-1β production. In summary, NLRP3 variants causing CAPS form a constitutively active inflammasome inducing pyroptosis and IL-18 release without cell priming, which enables the host's innate defence against pathogens while also limiting IL-1β-dependent inflammatory episodes through immunometabolism modulation, This work was supported by grants from MCIN/AEI/10.13039/501100011033 (grants PID2020-116709RB-I00, BG20/00060, CNS2022-135101 and RED2022-134511-T to PP), FEDER/Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación (grant SAF2017‐88276‐R to PP), Fundación Séneca (grants 20859/PI/18 and 21897/PI/22 to PP), the Instituto Salud Carlos III (grants DTS21/00080 and AC22/00009 to PP), the EU Horizon 2020 project PlasticHeal (grant 965196 to PP), the Spanish Ministry of Science, Innovation and Universities co-funded by the European Regional Development Fund / Agencia Estatal de Investigación (grant RTI2018-096824-B-C21 to JIA) and the Spanish Ministry of Science and Innovation / Agencia Estatal de Investigación (grant PID2021-125106OB-C31 to JIA). L.H-N. was supported by the fellowship 21214/FPI/19 (Fundación Séneca, Región de Murcia, Spain) and CM-L by was funded by the fellowship PRE2018-086824 (Ministerio economía y competitividad), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Excess of Carriers in Rare Disorders Suggests a Nonpathogenic Effect for Most Variants of Uncertain Significance

  • Medaglia, Stefano
  • Reig-Palou, Jaume
  • Bellés, Ariadna
  • Moreno-Ruiz, Nerea
  • Rodríguez, Jairo
  • Armengol, Xavier
  • Aróstegui, Juan Ignacio
  • Armengol, Lluís
  • Guillén, Juan José
  • Laayouni, Hafid
  • Casals, Ferran
Functional annotation and interpretation of genetic variants are a critical step in genetic diagnosis, as it may lead to personalized therapeutic options and genetic counseling. While the number of confirmed pathogenic genetic variants in an individual is relatively low, the number of variants of uncertain significance (VOUS) can be considerably higher, increasing the number of potential carriers of genetic disorders. Thus, reducing uncertainty and assessing the real effect of VOUS are crucial for clinical and medical genetics. In this study, we evaluated the efficacy of genetic screening technologies in accurately predicting pathogenic variants and their corresponding disease prevalence in a cohort of over 6000 healthy individuals involved in assisted reproduction programs. Using data from 305 genes associated with recessive disorders, we determined the frequency of carriers of pathogenic variants and VOUS in our dataset and compared the predicted prevalence based on this information with reported population prevalence data. The higher predicted prevalence in some disorders when considering VOUS suggests a mostly benign effect., This work was supported by grants RTI2018-096824-B-C22 (F.C.), PID2021-125106OB-C32 (F.C.), RTI2018-096824-B-C21(J.I.A.), and PID2021-125106OB-C31 (J.I.A.) funded by MCIN/AEI / 10.13039/501100011033/ and FEDER Una manera de hacer Europa; Agència de Gestió d'Ajuts Universitaris I de Recerca-Generalitat de Catalunya (2021SGR01093) (F.C.). N.M.-R. was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protective Effects of Interleukin-1 Inhibition With Anakinra in Mouse Models of Ischemic Stroke With and Without Reperfusion

  • Chaparro-Cabanillas, Nerea
  • Aliena-Valero, Alicia
  • Pedragosa, Jordi
  • Pedrosa, Leire
  • Honores, Milagros
  • Rossinyol-Boladeres, Mercè
  • Salom, Juan B.
  • Chamorro, Ángel
  • Arostegui, Juan Ignacio
  • Urra, Xabier
  • Justicia, Carles
  • Planas, Anna M.
Severe brain ischemia is associated with life-threatening edema and inflammation. Interleukin-1 is a crucial mediator of inflammation, and its blockade showed benefits in experimental stroke. We studied anakinra, a modified recombinant human interleukin-1 receptor antagonist, in mouse models of moderate to severe ischemia/reperfusion and large hemispheric infarctions. Due to anakinra's short half-life, we used a novel subcutaneous infusion protocol and tested 2 drug doses., Study funded by Instituto de Salud Carlos III, Ministerio de Salud (grant PI21/00966 to Dr Urra); Ministerio de Ciencia, Innovación y Universidades MCIN/AEI/10.13039/501100011033 and “ERDF: A way of making Europe” by the “European Union” (grants PID2020‐113202RB‐I00 and PID2023‐150949OB‐I00 to Dr Planas, and grant PID2021‐125106OB‐C31 to Dr Arostegui); “Fundació La Marató de TV3” (grant 202330‐10) to Dr Planas, and the RICORS‐Ictus network of Instituto de Salud Carlos III (RD21/0006/0013 and RD24‐0009‐0002 to Dr Chamorro and RD21/0006/0014 and RD24‐0009‐0003 to Dr Salom)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís Moruno, Manuel, 1993-
  • Batlle Masó, Laura, 1993-
  • Bonet, Núria
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaró, Jose Manuel
  • Tejedor Vaquero, Sonia, 1988-
  • Magri, Giuliana, 1978-
  • Bonet, Núria
  • Solís Moruno, Manuel, 1993-
  • Cerutti, Andrea, 1965-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
Background: The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. Objectives: To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Methods: Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Results: Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Conclusion: Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms., This work has been partially funded by RTI2018-096824-B-C21 (JIA) and RTI2018-096824-B-C22 (FC) grant from the Spanish Ministry of Science, Innovation and Universities co-funded by Agencia Estatal de Investigación/European Regional Development Fund una manera de hacer Europa. PID2021-125106OB-C31 (JIA) and PID2021-125106OB-C32 (FC) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | 10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE.PI19/01567 grant from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (AM-V).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism

  • Bonet, Núria
  • Pesqué, David
  • Giménez Arnau, Anna Maria
  • Laayouni, Hafid, 1968-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease., This work has been partially funded by: • PID2021-125106OB-C31 (JIA), PID2020-116709RB-I00 (PP), CNS2022-135101 (PP), PID2023-147531OB-I00 (PP), PID2021-125106OB-C32 (FC), RED2022-134511-T (PP, JIA) and PID2021-125106OB-C33 (OF) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | https://doi.org/10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE | European Union «Next Generation EU/PRTR». • AC21_2/00042 (JIA) and IFI22/00031 (JG-V) grants from the Instituto de Salud Carlos III co-funded by Unión Europea Next Generation EU | Mecanismo para la Recuperación y la Resiliencia (MRR) | Plan de Recuperación, Transformación y Resiliencia (PRTR). • 2021SGR01093 | Agència de Gestió d’Ajuts Universitaris i de Recerca | Generalitat de Catalunya (FC). • 21897/PI/22 (PP) and 21214/FPI/19 (LH-N) | Fundación Séneca, Región de Murcia, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Genomics England Research Consortium
  • Lao Grueso, Oscar, 1976-
  • Aróstegui Gorospe, Juan Ignacio
  • Laayouni, Hafid, 1968-
  • Casals López, Ferran
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís-Moruno, Manuel|||0000-0001-7407-8896
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Bonet, Núria|||0000-0003-0574-2575
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
  • Casals, Ferran|||0000-0002-8941-0369
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome, clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaro, Jose Manuel|||0000-0001-9327-2555
  • Rodriguez-Pinto, Ignasi
  • Poza, Gabriela
  • Mensa-Vilaro, Anna|||0000-0001-7541-9672
  • Fernández-Martín, Julián|||0000-0002-9391-4316
  • Caminal-Montero, Luis|||0000-0002-4044-8235
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Diaz, Marina
  • Rita-Marques, Joana
  • Sanmartí, Raimon|||0000-0002-8864-3806
  • Castañeda, Santos|||0000-0002-7748-853X
  • Colunga, Dolores
  • Coto-Hernández, Rubén
  • Fanlo, Patricia
  • Elejalde, Jose Ignacio
  • Segundo, Bujan
  • Figueras, Ignasi
  • Marco, Francisco Manuel
  • Andrés, Mariano|||0000-0002-0219-9055
  • Suárez Díaz, Silvia|||0000-0002-8558-5452
  • Gonzalez-Garcia, Andres
  • Fustà-Novell, Xavier|||0000-0001-6631-6030
  • Garcia-Belando, Clara
  • Granados-Maturano, Ana|||0000-0002-5323-5909
  • Fernández-Figueras, Maria Teresa|||0000-0002-2366-7110
  • Quilis, Neus|||0000-0001-7509-7212
  • Orriols-Caba, Maria
  • Gómez de la Torre, Ricardo
  • Cid, María Cinta|||0000-0002-4730-0938
  • Espígol Frigolé, Georgina|||0000-0002-8299-0209
  • Alvarez-Abella, Alba
  • Labrador, Eztizen
  • Rozman, Maria|||0000-0002-2641-1110
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Castillo, Paola|||0000-0002-9284-8601
  • Álamo, José Ramón
  • González Roca, Eva|||0000-0002-1126-0321
  • Plaza, Susana
  • Fabregat, Virginia
  • Lara, Rocio
  • Vicente-Rabaneda, Esther F.
  • Tejedor Vaquero, Sonia|||0000-0003-2873-4981
  • Magri, Giuliana|||0000-0002-0163-3542
  • Bonet, Nuria
  • Solis-Moruno, Manuel
  • Cerutti, Andrea|||0000-0003-3026-4704
  • Fornas, Òscar|||0000-0003-2017-9100
  • Casals, Ferran|||0000-0002-8941-0369
  • Yagüe, Jordi|||0000-0001-8210-1929
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms.